Publication Type Academic Article
Authors Hojjati S, Chiang G, Butler T, de Leon M, Gupta A, Li Y, Sabuncu M, Feiz F, Nayak S, Shteingart J, Ozoria S, Gholipour Picha S, Stern Y, Luchsinger J, Devanand D, Razlighi Q
Journal J Alzheimers Dis
Volume 98
Issue 4
Pagination 1467-1482
Date Published 01/01/2024
ISSN 1875-8908
Keywords Alzheimer Disease, Cognitive Dysfunction, Proteostasis Deficiencies
Abstract BACKGROUND: Histopathologic studies of Alzheimer's disease (AD) suggest that extracellular amyloid-β (Aβ) plaques promote the spread of neurofibrillary tau tangles. However, these two proteinopathies initiate in spatially distinct brain regions, so how they interact during AD progression is unclear. OBJECTIVE: In this study, we utilized Aβ and tau positron emission tomography (PET) scans from 572 older subjects (476 healthy controls (HC), 14 with mild cognitive impairment (MCI), 82 with mild AD), at varying stages of the disease, to investigate to what degree tau is associated with cortical Aβ deposition. METHODS: Using multiple linear regression models and a pseudo-longitudinal ordering technique, we investigated remote tau-Aβ associations in four pathologic phases of AD progression based on tau spread: 1) no-tau, 2) pre-acceleration, 3) acceleration, and 4) post-acceleration. RESULTS: No significant tau-Aβ association was detected in the no-tau phase. In the pre-acceleration phase, the earliest stage of tau deposition, associations emerged between regional tau in medial temporal lobe (MTL) (i.e., entorhinal cortex, parahippocampal gyrus) and cortical Aβ in lateral temporal lobe regions. The strongest tau-Aβ associations were found in the acceleration phase, in which tau in MTL regions was strongly associated with cortical Aβ (i.e., temporal and frontal lobes regions). Strikingly, in the post-acceleration phase, including 96% of symptomatic subjects, tau-Aβ associations were no longer significant. CONCLUSIONS: The results indicate that associations between tau and Aβ are stage-dependent, which could have important implications for understanding the interplay between these two proteinopathies during the progressive stages of AD.
DOI 10.3233/JAD-231362
PubMed ID 38552116
PubMed Central ID PMC11091581
Back to Top